Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.60 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | NAMPT | P43490 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | F2R | P25116 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2678008 | 1.00 | NAAA (0.62) | NAAAEPHX2KEAP1NFE2L2EPHX1 | |
| SCHEMBL5902012 | 0.98 | NAAA (0.59) | NAAAEPHX2KEAP1NFE2L2EPHX1 | |
| SCHEMBL9829575 | 0.95 | NAAA (0.65) | NAAAEPHX2KEAP1NFE2L2EPHX1 | |
| SCHEMBL7897834 | 0.93 | NAAA (0.68) | NAAAEPHX2KEAP1NFE2L2EPHX1 | |
| SCHEMBL5655426 | 0.93 | NAAA (0.68) | NAAAEPHX2KEAP1NFE2L2EPHX1 | |
| SCHEMBL9831292 | 0.93 | NAAA (0.62) | NAAAEPHX2KEAP1NFE2L2EPHX1 | |
| SCHEMBL9830181 | 0.91 | NAAA (0.65) | NAAAEPHX2KEAP1NFE2L2EPHX1 | |
| SCHEMBL2331473 | 0.90 | EPHX2 (0.51) | NAAAEPHX2KEAP1NFE2L2EPHX1 | |
| SCHEMBL9951287 | 0.89 | NAAA (0.56) | NAAAEPHX2KEAP1NFE2L2EPHX1 | |
| SCHEMBL19359643 | 0.89 | NAAA (0.56) | NAAAEPHX2KEAP1NFE2L2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220133685-A1 | FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS | RECEPTOR HOLDINGS, INC. (US) | 2022-05-05 | — | — | US | disclosed |
| US-11246852-B2 | Fast-acting plant-based medicinal compounds and nutritional supplements | RECEPTOR HOLDINGS, INC. (US) | 2022-02-15 | — | — | US | disclosed |
| US-20210393575-A1 | N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID BASED COMPOSITIONS | RECEPTOR HOLDINGS, INC. (US) | 2021-12-23 | — | — | US | disclosed |
| US-20200101034-A1 | RAPID AND CONTROLLED DELIVERY OF COMPOSITIONS WITH RESTORED ENTOURAGE EFFECTS | RECEPTOR HOLDINGS, INC. (US) | 2020-04-02 | — | — | US | disclosed |
| US-7417022-B2 | Compounds and compositions for delivering active agents | MHR INSTITUTIONAL PARTNERS IIA LP (US) | 2008-08-26 | — | — | US | disclosed |
| US-7417022-B2 | Compounds and compositions for delivering active agents | MHR INSTITUTIONAL PARTNERS IIA LP (US) | 2008-08-26 | — | — | US | disclosed |
| EP-1792624-A1 | Modified amino acids and compositions comprising them for delivering active agents | Emisphere Technologies, Inc. (US) | 2007-06-06 | — | — | EP | disclosed |
| US-6878708-B2 | Imidazotriazinones and the use thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2005-04-12 | — | — | US | disclosed |
| US-20040097498-A1 | Novel imidazotriazinones and the use thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2004-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097498-A1 | Novel imidazotriazinones and the use thereof | CYP4F3, CYP4F2, CYP3A7 | NAAA 3998/4885EPHX2 2796/4885KEAP1 2014/4885 |
| US-11246852-B2 | Fast-acting plant-based medicinal compounds and nutritional supplements | SLC1A5, SLC43A1, SLC27A2 | NAAA 152/4885EPHX2 4247/4885KEAP1 1617/4885 |
| US-20200101034-A1 | RAPID AND CONTROLLED DELIVERY OF COMPOSITIONS WITH RESTORED ENTOURAGE EFFECTS | FABP2, ASS1, AADAT | NAAA 88/4885EPHX2 2470/4885KEAP1 4387/4885 |
| US-20210393575-A1 | N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID BASED COMPOSITIONS | FAAH, CNR2, FABP2 | NAAA 39/4885EPHX2 1872/4885KEAP1 4222/4885 |
| US-20220133685-A1 | FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS | SLC1A5, SLC43A1, SLC27A2 | NAAA 152/4885EPHX2 4247/4885KEAP1 1617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.